Publications by authors named "Marja Sankelo"

12Publications

CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA study.

Transfusion 2020 Jul 24;60(7):1519-1528. Epub 2020 Apr 24.

Department of Medicine, Kuopio University Hospital, Kuopio, Finland.

View Article and Find Full Text PDF

July 2020

RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group.

Ann Hematol 2019 Dec 31;98(12):2781-2792. Epub 2019 Oct 31.

Comprehensive Cancer Center, Department of Hematology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

View Article and Find Full Text PDF

December 2019

Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study.

Authors:

Jaakko Valtola Raija Silvennoinen Antti Ropponen Timo Siitonen Marjaana Säily Marja Sankelo Mervi Putkonen Anu Partanen Marja Pyörälä Eeva-Riitta Savolainen Pentti Mäntymaa Jukka Pelkonen Esa Jantunen Ville Varmavuo

Leuk Lymphoma 2019 02 30;60(2):453-461. Epub 2018 Aug 30.

k Department of Medicine , Kymenlaakso Central Hospital , Kotka , Finland.

View Article and Find Full Text PDF

February 2019

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.

Clin Infect Dis 2017 Nov;65(11):1819-1828

Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

View Article and Find Full Text PDF

November 2017

Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.

Authors:

Aarne Kolonen Marjatta Sinisalo Reetta Huttunen Jaana Syrjänen Janne Aittoniemi Heini Huhtala Marja Sankelo Hannele Rintala Riikka Räty Esa Jantunen Tapio Nousiainen Marjaana Säily Marjut Kauppila Maija Itälä-Remes Hanna Ollikainen Auvo Rauhala Pirjo Koistinen Erkki Elonen

Infect Dis (Lond) 2017 Nov - Dec;49(11-12):799-808. Epub 2017 Jul 6.

d Department of Hematology , Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Finland.

View Article and Find Full Text PDF

April 2018

Impact of lenalidomide-based induction therapy on the mobilization of CD34 cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.

Authors:

Anu Partanen Jaakko Valtola Raija Silvennoinen Antti Ropponen Timo Siitonen Mervi Putkonen Marja Sankelo Jukka Pelkonen Pentti Mäntymaa Ville Varmavuo Esa Jantunen

Transfusion 2017 10 5;57(10):2366-2372. Epub 2017 Jul 5.

Department of Medicine, Kuopio University Hospital, Kuopio, Finland.

View Article and Find Full Text PDF

October 2017

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

Authors:

Ville Varmavuo Raija Silvennoinen Pekka Anttila Marjaana Säily Marja Sankelo Mervi Putkonen Jouni Ahonen Eija Mahlamäki Pentti Mäntymaa Eeva-Riitta Savolainen Kari Remes Esa Jantunen

Ann Hematol 2016 Oct 3;95(10):1653-9. Epub 2016 Aug 3.

Department of Medicine, Kuopio University Hospital, Kuopio, Finland.

View Article and Find Full Text PDF

October 2016

Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.

Authors:

Jaakko Valtola Raija Silvennoinen Antti Ropponen Timo Siitonen Marjaana Säily Marja Sankelo Venla Terävä Mervi Putkonen Taru Kuittinen Jukka Pelkonen Pentti Mäntymaa Kari Remes Ville Varmavuo Esa Jantunen

Transfusion 2016 06 4;56(6):1394-401. Epub 2016 Apr 4.

Department of Medicine, Kuopio University Hospital, Kuopio, Finland.

View Article and Find Full Text PDF

June 2016

Accurate genetic diagnosis of Finnish pulmonary arterial hypertension patients using oligonucleotide-selective sequencing.

Authors:

Sanna Vattulainen Joonas Aho Pertteli Salmenperä Siina Bruce Jonna Tallila Massimiliano Gentile Marja Sankelo Tarja Laitinen Juha W Koskenvuo Tero-Pekka Alastalo Samuel Myllykangas

Mol Genet Genomic Med 2015 Jul 25;3(4):354-62. Epub 2015 Apr 25.

Blueprint Genetics Helsinki, Finland ; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki Helsinki, Finland.

View Article and Find Full Text PDF

July 2015

Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.

Authors:

Marjatta Sinisalo Marja Sankelo Maija Itälä-Remes

Leuk Lymphoma 2011 Apr 16;52(4):724-5. Epub 2011 Feb 16.

View Article and Find Full Text PDF

April 2011

Hereditary hemorrhagic telangiectasia type 1 and 2 mutations in Finland.

Authors:

Marja Sankelo Maija Halme Tarja Laitinen Petri S Mattila

Acta Otolaryngol 2008 Nov;128(11):1238-41

Department of Medical Genetics, University of Helsinki, Helsinki, Finland.

View Article and Find Full Text PDF

November 2008

BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension.

Authors:

Marja Sankelo Julia A Flanagan Rajiv Machado Rachel Harrison Nung Rudarakanchana Nicholas Morrell Morag Dixon Maija Halme Hannu Puolijoki Juha Kere Outi Elomaa Markku Kupari Anne Räisänen-Sokolowski Richard C Trembath Tarja Laitinen

Hum Mutat 2005 Aug;26(2):119-24

Department of Medical Genetics, University of Helsinki, Helsinki, Finland.

View Article and Find Full Text PDF

August 2005